SCHEMBL20867295

SCHEMBL20867295

N=C(ON)c1nc(C2(C(F)(F)F)CCC2)sc1N1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20867257 0.84 SYK (0.31) —
SCHEMBL20866963 0.84 PIK3CD (0.30) —
SCHEMBL20866762 0.81 PIK3CA (0.30) —
SCHEMBL24612188 0.81 PIK3CD (0.30) —
SCHEMBL20866691 0.79 MAPK1 (0.31) —
SCHEMBL20866838 0.76 ATM (0.32) —
SCHEMBL20867306 0.74 ATM (0.31) —
SCHEMBL24612210 0.72 FBP1 (0.31) —
SCHEMBL24612293 0.70 ATM (0.31) —
SCHEMBL20866960 0.69 ATM (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback